Published in Cancer Weekly, September 8th, 2009
"The study reviews characteristics and overall survival (OS) of CRC in patients a parts per thousand currency sign50 years old. Five hundred and twenty-three (14%) of 3,796 sporadic CRCs were identified. were compared for demographics, tumour characteristics, treatment, and 5-year overall specific survival. Independent prognostic factors were evaluated. The majority were males (54%) with a median age of 45 years (range 19-50 years). Sixty-three percent of the patients presented with advanced stage disease (stage III and IV), and tumours...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.